PLUS1
4.23
-0.10 (-2.31%)
-0.10 (-2.31%)
Upgrade to Real-Time
Regular Market
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | CRVS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Previous Close | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.10 | -2.31% | 4.23 | 4.197 | 4.42 | 4.35 | 4.33 | 11:13:56 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 4.22 | 4.24 | 0.02 | 0.47% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 335 | 68,168 | $ 4.30 | $ 292,891 | 4,160,897 | 1.01 - 8.93 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 11:13:56 | 100 | $ 4.23 | USD |
Corvus Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 118.24M | 27.95M | 27.69M | $ - | $ - | -1.59 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Corvus Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 8/04/2020 | 16:05 | GlobeNewswire Inc. | Corvus Pharmaceuticals to Present at the 2020 Wedbush.. |
| 7/30/2020 | 18:47 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 7/30/2020 | 18:42 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 7/30/2020 | 16:02 | GlobeNewswire Inc. | Corvus Pharmaceuticals Provides Business Update and Reports.. |
| 7/23/2020 | 08:30 | GlobeNewswire Inc. | Corvus Pharmaceuticals to Provide Business Update and Report.. |
| 7/07/2020 | 07:18 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 7/07/2020 | 07:00 | GlobeNewswire Inc. | Corvus Pharmaceuticals Initiates Clinical Trial of Novel.. |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical CRVS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 3.98 | 4.42 | 3.8648 | 4.22 | 351,836 | 0.25 | 6.28% |
| 1 Month | 4.75 | 5.19 | 3.50 | 4.23 | 732,751 | -0.52 | -10.95% |
| 3 Months | 3.54 | 8.93 | 2.51 | 4.83 | 2,212,511 | 0.69 | 19.49% |
| 6 Months | 5.21 | 8.93 | 1.01 | 4.70 | 1,096,865 | -0.98 | -18.81% |
| 1 Year | 3.54 | 8.93 | 1.01 | 4.61 | 623,279 | 0.69 | 19.49% |
| 3 Years | 12.20 | 17.635 | 1.01 | 5.41 | 279,647 | -7.97 | -65.33% |
| 5 Years | 15.00 | 22.1366 | 1.01 | 6.21 | 217,779 | -10.77 | -71.8% |
Corvus Pharmaceuticals Description
| Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on developing and commercializing small-molecule and antibody agents that target the immune system to treat patients with cancer. The firm's pipeline includes CPI-006, CPI-818, CPI-935, and others. |
